Page last updated: 2024-11-02

1,2-cyclohexanediamine and Ovarian Neoplasms

1,2-cyclohexanediamine has been researched along with Ovarian Neoplasms in 2 studies

1,2-cyclohexanediamine: RN given refers to cpd without isomeric designation

Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yoshida, M1
Khokhar, AR1
Siddik, ZH1
Schmidt, W1
Chaney, SG1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase II Study of Trastuzumab in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer[NCT01396707]Phase 255 participants (Actual)Interventional2011-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for 1,2-cyclohexanediamine and Ovarian Neoplasms

ArticleYear
Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines.
    Cancer research, 1994, Jul-01, Volume: 54, Issue:13

    Topics: Animals; Antineoplastic Agents; Cisplatin; Cyclohexylamines; DNA, Neoplasm; Drug Resistance; Female;

1994
Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Cancer research, 1993, Feb-15, Volume: 53, Issue:4

    Topics: Antineoplastic Agents; Cisplatin; Colonic Neoplasms; Cyclohexylamines; DNA Repair; DNA, Neoplasm; Dr

1993